Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

286.39 -0.35 (-0.12%)

Official Closing Price Updated: 7:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

96 97 Next >

Billionaire Ken Griffin Is Buying This Dividend King That Wall Street Still Rates a Buy ↗

October 26, 2026

Despite its high price relative to earnings, AbbVie remains an attractive stock.

Via The Motley Fool

3 Stocks With Yields Big Enough to Make Election Volatility Easier to Stomach ↗

October 23, 2026

Lincoln National, AbbVie and Phillips 66 offer dividends that pay investors through midterm volatility, backed by rising rates, steady drug demand and oil risk.

Via MarketBeat

What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and Pfizer ↗

October 22, 2026

They definitely matter... up to a point.

Via The Motley Fool

Topics Bonds Economy

Great News for AbbVie Stock Investors ↗

October 22, 2026

The company is gearing up for future major patent cliffs.

Via The Motley Fool

Topics Intellectual Property

Cannabis Stocks’ Rally Is Narrow as Profitable Healthcare and Consumer Names Do the Heavy Lifting ↗

October 22, 2026

Via Chartmill

Topics Cannabis

AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue? ↗

October 21, 2026

AbbVie's revenue lead has widened to $4 billion per quarter, but Bristol Myers shows surprising resilience despite slower growth.

Via The Motley Fool

Topics Intellectual Property

AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗

October 20, 2026

AbbVie generates $17.8 billion in annual free cash flow but faces patent cliffs, while Vertex boasts a 33% net margin with concentrated cystic fibrosis exposure.

Via The Motley Fool

Topics Intellectual Property

Kevin Warsh's Fed May Not Cut Rates Soon. That's Why This Dividend Stock Belongs in Your Portfolio. ↗

October 20, 2026

This pharma leader has a history of outperforming during rising interest rates.

Via The Motley Fool

Topics Bonds Economy

2 High-Flying Dividend Stocks to Buy and Hold for a Decade ↗

October 19, 2026

They may just be getting started.

Via The Motley Fool

Topics Intellectual Property

Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It ↗

October 19, 2026

Buffett has warned about "gambling" in the market.

Via The Motley Fool

Topics Intellectual Property Retirement

Ken Griffin Increased His Position in This Dividend King by a Whopping 546% in Q2. Here's Why It's Still a Buy. ↗

October 18, 2026

It was Griffin's biggest add for Citadel last quarter.

Via The Motley Fool

Topics Economy

Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle ↗

October 17, 2026

Rising rates can expose dividend traps, but this Dividend King is built to keep paying.

Via The Motley Fool

Topics Credit Cards

If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys ↗

October 17, 2026

These funds can help you weather any storm that might be on the way.

Via The Motley Fool

Topics ETFs Stocks

Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends ↗

October 16, 2026

You'd need to invest over $200,000 in the pharma leader at its current price.

Via The Motley Fool

Topics Intellectual Property

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗

October 15, 2026

AbbVie is raising its outlook with Skyrizi and Rinvoq offsetting Humira losses. Pfizer is rebuilding its pipeline around obesity drugs and key readouts expected over the next year.

Via The Motley Fool

Topics Intellectual Property

Stock Market Today: Hot Inflation and a Neocloud Shakeout Sink the Nasdaq ↗

October 15, 2026

Via Chartmill

Topics Economy

Top S&P500 movers in Wednesday's session ↗

October 14, 2026

Via Chartmill

Exploring the top movers within the S&P500 index during today's session. ↗

October 14, 2026

Via Chartmill

1 S&P 500 Stock with Competitive Advantages and 2 We Brush Off

October 14, 2026

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Via StockStory

Topics Stocks

AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? ↗

October 13, 2026

One faces patent cliffs and revenue concentration; the other dominates a booming market but trades at a premium valuation.

Via The Motley Fool

Topics Intellectual Property

AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? ↗

October 12, 2026

AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium.

Via The Motley Fool

AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway. ↗

October 11, 2026

A super-high yield isn't everything.

Via The Motley Fool

Topics Intellectual Property

How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? ↗

October 10, 2026

You'll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and Bristol Myers Squibb.

Via The Motley Fool

Topics Intellectual Property

A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens ↗

October 09, 2026

These companies might bend during a downturn, but they won’t break.

Via The Motley Fool

Topics Economy Intellectual Property

2 Cash-Producing Stocks on Our Watchlist and 1 We Avoid

October 09, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

Topics Energy

5 Stocks to Buy That Have Raised Their Dividends Every Year Since 2000 ↗

October 07, 2026

Each of these stocks, representing a different sector, is on an impressive run of dividend growth.

Via The Motley Fool

Topics Artificial Intelligence

Wednesday's session: top gainers and losers in the S&P500 index ↗

October 07, 2026

Via Chartmill

3 of the Best Growth Stocks to Buy in October 2026 ↗

October 06, 2026

These stocks have tremendous businesses, and their valuations are incredibly low.

Via The Motley Fool

Topics Artificial Intelligence

HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English. ↗

October 06, 2026

A recent analyst lays out a concrete bull case, but it is not the only path to higher prices for AbbVie.

Via The Motley Fool

Should You Buy AbbVie Stock Before Oct. 30? ↗

October 06, 2026

The healthcare company will release its third-quarter numbers later this month.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

96 97 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.